Symbol="RCUS"
AssetType="Common Stock"
Name="Arcus Biosciences Inc"
Description="Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California."
CIK="1724521"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3928 POINT EDEN WAY, HAYWARD, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1348067000"
EBITDA="-292000000"
PERatio="None"
PEGRatio="None"
BookValue="8.21"
DividendPerShare="0"
DividendYield="0"
EPS="-3.69"
RevenuePerShareTTM="1.643"
ProfitMargin="-2.345"
OperatingMarginTTM="-2.513"
ReturnOnAssetsTTM="-0.134"
ReturnOnEquityTTM="-0.4"
RevenueTTM="119000000"
GrossProfitTTM="-176000000"
DilutedEPSTTM="-3.69"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.389"
AnalystTargetPrice="42.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="5.19"
PriceToBookRatio="3.149"
EVToRevenue="2.936"
EVToEBITDA="14.1"
Beta="0.837"
num_52WeekHigh="36.13"
num_52WeekLow="15.7"
num_50DayMovingAverage="20.07"
num_200DayMovingAverage="21.27"
SharesOutstanding="73106000"
DividendDate="None"
ExDividendDate="None"
symbol="RCUS"
open="18.34"
high="18.82"
low="18.19"
price="18.21"
volume="420828.00"
latest_trading_day="2023-08-11"
previous_close="18.44"
change="-0.23"
change_percent="-1.2473%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="967668"
Change_recent_avg="-0.01"
Delta_recent_avg="0.99"
Variance_recent_avg="0.49"
Change_ratio_recent_avg="-0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0073.jpeg"
image_negative_thumbnail_id_2="488"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_neutral_thumbnail_id_1="572"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="987"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
